[Federal Register Volume 84, Number 131 (Tuesday, July 9, 2019)]
[Notices]
[Page 32785]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14516]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on July 24, 2019, to discuss the NRC's Abnormal 
Occurrence Criteria and the ACMUI subcommittee's report on a draft 
guidance document. Meeting information, including a copy of the agenda 
and publicly available handouts, will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html. The 
agenda and handouts may also be obtained by contacting Ms. Kellee 
Jamerson using the contact information below.
    Date and Time for Open Session: July 24, 2019, from 10:00 a.m. to 
10:30 a.m. Eastern Standard Time (EST).
    Date and Time for Closed Session: July 24, 2019, from 10:30 a.m. to 
12:00 p.m. (EST). This session will be closed to discuss information of 
which the premature disclosure would likely significantly frustrate 
implementation of a proposed agency action.
    Public Participation: Any member of the public who wishes to 
participate in the open session of the teleconference should contact 
Ms. Jamerson using the contact information below or may register for 
the GoToWebinar at https://attendee.gotowebinar.com/register/1516330288686216460 for the July 24, 2019, meeting.

FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, email: 
[email protected], telephone: (301) 415-7408.

Conduct of the Meeting

    Dr. Christopher Palestro, ACMUI Chairman, will preside over the 
meeting. Dr. Palestro will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson at the contact information listed 
above. All submittals must be received by July 19, 2019, three business 
days prior to the July 24, 2019, meeting, and must pertain to the topic 
on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about September 5, 2019.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations part 7.

    Dated: July 3, 2019.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-14516 Filed 7-8-19; 8:45 am]
 BILLING CODE 7590-01-P